Denifanstat

CAS No.

1399177-37-7

MDL No.

N/A

C₂₇H₂₉N₅O

439.60

InChI Key

BBGOSBDSLYHMRA-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
1 mg	98%	$41	In Stock
5 mg	98%	$98	In Stock
50 mg	98%	$415	In Stock
250 mg	98%	$1194	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

98%

$41

In Stock

5 mg

98%

$98

In Stock

50 mg

98%

$415

In Stock

250 mg

98%

$1194

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Denifanstat is an orally bioavailable FASN inhibitor with antineoplastic activity. It binds to FASN, preventing palmitate synthesis essential for tumor cell growth and survival.

CAS No.	1399177-37-7
Product Name	Denifanstat

Heavy Atom Count	33	Rotatable Bond Count	4
Atom Stereo Count	0	Bond Stereo Count	0
HBA	4	HBD	1
TPSA	85.670 Å²	Charge	0
Exact Mass	439.23721	Complexity	1208.30
pKa	5.875	XLogP	5.248

Pricing & Availability

Product Information

Properties

Documentation

Denifanstat

Pricing & Availability

Product Information

Properties

Related Articles

Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer.

Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer.

Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.

Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion.

Documentation